IL6(白细胞介素6)是一种多功能细胞因子,属于白细胞介素家族,在免疫调节、炎症反应、造血和代谢过程中发挥核心作用。它主要由T细胞、巨噬细胞、内皮细胞和脂肪细胞产生,通过结合IL6受体(IL6R)和gp130信号转导蛋白激活JAK-STAT、MAPK和PI3K通路,影响靶细胞的增殖、分化和功能。IL6在急性炎症中起保护作用,促进肝细胞产生急性期蛋白(如C反应蛋白)和发热反应,同时刺激B细胞分化为浆细胞以增强抗体产生。然而,IL6的持续过表达与多种慢性炎症性疾病和自身免疫疾病相关,如类风湿性关节炎、克罗恩病和 Castleman病,还参与某些癌症(如多发性骨髓瘤)的发展,促进肿瘤细胞增殖和血管生成。IL6基因突变可能导致异常信号传导,例如IL6受体增益性突变与幼年特发性关节炎相关,而功能丧失突变可能增加感染风险。IL6过表达会加剧炎症反应和组织损伤,而降低表达可能削弱免疫防御但减轻炎症性疾病症状。IL6属于白细胞介素家族,该家族成员均为细胞因子,主要调节免疫细胞间的通讯和炎症反应。针对IL6或其受体的单克隆抗体(如托珠单抗)已用于治疗类风湿性关节炎和细胞因子风暴(如COVID-19重症病例),体现了其作为治疗靶点的重要性。
None
无
IL6基因(以及对应的蛋白质)的细胞分布位置:
IL6基因的本体(GO)信息:
名称 |
---|
4630 Jak-STAT signaling pathway [PATH:hsa04630] |
4668 TNF signaling pathway [PATH:hsa04668] |
4066 HIF-1 signaling pathway [PATH:hsa04066] |
4068 FoxO signaling pathway [PATH:hsa04068] |
4151 PI3K-Akt signaling pathway [PATH:hsa04151] |
4060 Cytokine-cytokine receptor interaction [PATH:hsa04060] |
4640 Hematopoietic cell lineage [PATH:hsa04640] |
4620 Toll-like receptor signaling pathway [PATH:hsa04620] |
4621 NOD-like receptor signaling pathway [PATH:hsa04621] |
4623 Cytosolic DNA-sensing pathway [PATH:hsa04623] |
4672 Intestinal immune network for IgA production [PATH:hsa04672] |
5200 Pathways in cancer [PATH:hsa05200] |
5202 Transcriptional misregulation in cancers [PATH:hsa05202] |
5323 Rheumatoid arthritis [PATH:hsa05323] |
5321 Inflammatiory bowel disease (IBD) [PATH:hsa05321] |
5332 Graft-versus-host disease [PATH:hsa05332] |
5020 Prion diseases [PATH:hsa05020] |
5410 Hypertrophic cardiomyopathy (HCM) [PATH:hsa05410] |
4932 Non-alcoholic fatty liver disease (NAFLD) [PATH:hsa04932] |
5132 Salmonella infection [PATH:hsa05132] |
5133 Pertussis [PATH:hsa05133] |
5134 Legionellosis [PATH:hsa05134] |
5152 Tuberculosis [PATH:hsa05152] |
5166 HTLV-I infection [PATH:hsa05166] |
5162 Measles [PATH:hsa05162] |
5164 Influenza A [PATH:hsa05164] |
5161 Hepatitis B [PATH:hsa05161] |
5168 Herpes simplex infection [PATH:hsa05168] |
5146 Amoebiasis [PATH:hsa05146] |
5144 Malaria [PATH:hsa05144] |
5142 Chagas disease (American trypanosomiasis) [PATH:hsa05142] |
5143 African trypanosomiasis [PATH:hsa05143] |
名称 |
---|
Activated TLR4 signalling |
ARMS-mediated activation |
Axon guidance |
Cellular responses to stress |
Cellular Senescence |
Cytokine Signaling in Immune system |
DAP12 interactions |
DAP12 signaling |
Developmental Biology |
Downstream signal transduction |
Downstream signaling of activated FGFR1 |
Downstream signaling of activated FGFR2 |
Downstream signaling of activated FGFR3 |
Downstream signaling of activated FGFR4 |
ERK activation |
ERK1 activation |
ERK2 activation |
Fc epsilon receptor (FCERI) signaling |
FCERI mediated MAPK activation |
FRS-mediated FGFR1 signaling |
FRS-mediated FGFR2 signaling |
FRS-mediated FGFR3 signaling |
Frs2-mediated activation |
FRS2-mediated FGFR4 signaling |
Gastrin-CREB signalling pathway via PKC and MAPK |
GRB2 events in EGFR signaling |
GRB2 events in ERBB2 signaling |
IGF1R signaling cascade |
Immune System |
Innate Immune System |
Insulin receptor signalling cascade |
Interleukin-2 signaling |
Interleukin-6 signaling |
IRS-mediated signalling |
IRS-related events |
IRS-related events triggered by IGF1R |
MAP kinase activation in TLR cascade |
MyD88 cascade initiated on plasma membrane |
MyD88 dependent cascade initiated on endosome |
MyD88-independent TLR3/TLR4 cascade |
MyD88:Mal cascade initiated on plasma membrane |
NCAM signaling for neurite out-growth |
NGF signalling via TRKA from the plasma membrane |
Prolonged ERK activation events |
RAF/MAP kinase cascade |
Senescence-Associated Secretory Phenotype (SASP) |
SHC-mediated signalling |
SHC-related events |
SHC-related events triggered by IGF1R |
SHC1 events in EGFR signaling |
SHC1 events in ERBB2 signaling |
SHC1 events in ERBB4 signaling |
Signal Transduction |
Signaling by EGFR |
Signaling by ERBB2 |
Signaling by ERBB4 |
Signaling by FGFR |
Signaling by FGFR1 |
Signaling by FGFR2 |
Signaling by FGFR3 |
Signaling by FGFR4 |
Signaling by GPCR |
Signaling by Insulin receptor |
Signaling by Interleukins |
Signaling by Leptin |
Signaling by PDGF |
Signaling by SCF-KIT |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) |
Signaling by VEGF |
Signalling by NGF |
Signalling to ERKs |
Signalling to p38 via RIT and RIN |
Signalling to RAS |
SOS-mediated signalling |
Toll Like Receptor 10 (TLR10) Cascade |
Toll Like Receptor 2 (TLR2) Cascade |
Toll Like Receptor 3 (TLR3) Cascade |
Toll Like Receptor 4 (TLR4) Cascade |
Toll Like Receptor 5 (TLR5) Cascade |
Toll Like Receptor 7/8 (TLR7/8) Cascade |
Toll Like Receptor 9 (TLR9) Cascade |
Toll Like Receptor TLR1:TLR2 Cascade |
Toll Like Receptor TLR6:TLR2 Cascade |
Toll-Like Receptors Cascades |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
TRAF6 Mediated Induction of proinflammatory cytokines |
TRIF-mediated TLR3/TLR4 signaling |
VEGFA-VEGFR2 Pathway |
VEGFR2 mediated cell proliferation |
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Diabetes Mellitus, Non-Insulin-Dependent | 0.420661594 | 76 | 2 | BeFree_CLINVAR_CTD_human_GAD_LHGDN_RGD |
Obesity | 0.289229902 | 116 | 5 | BeFree_CTD_human_GAD_RGD |
Rheumatoid Arthritis, Systemic Juvenile | 0.240271442 | 1 | 0 | BeFree_CTD_human_ORPHANET |
Multiple Myeloma | 0.225615597 | 239 | 1 | BeFree_CTD_human_GAD_LHGDN |
Inflammation | 0.219070452 | 70 | 0 | CTD_human_GAD_LHGDN |
Rheumatoid Arthritis | 0.212623944 | 187 | 5 | BeFree_CTD_human_GAD_LHGDN |
Heart failure | 0.205081451 | 15 | 0 | BeFree_CTD_human_GAD_RGD |
Depressive disorder | 0.203800186 | 15 | 0 | BeFree_CTD_human_RGD |
Reperfusion Injury | 0.202367032 | 7 | 0 | CTD_human_GAD_RGD |
Diabetes Mellitus, Experimental | 0.2 | 4 | 0 | CTD_human_RGD |
山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼
电话: 0531-88819269
E-mail: product@genelibs.com
关注微信订阅号,实时查看信息,关注医学生物学动态。